Assessment of Efficacy, Safety of mRNA COVID-19 Vaccines in Children Ages 5 to 11 – For The Media – JAMA Network



Assessment of Efficacy, Safety of mRNA COVID-19 Vaccines in Children Ages 5 to 11

JAMA Pediatrics


Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

About The Study: In this systematic review and meta-analysis including 17 studies with 10.9 million vaccinated and 2.6 million unvaccinated children ages 5 to 11, mRNA COVID-19 vaccination was associated with lower risks of SARS-CoV-2 infections, severe COVID-19–related illnesses, and hospitalizations due to COVID-19. While vaccination, compared with placebo, was associated with higher incidences of adverse events, the overall frequency of severe adverse events was low.

Authors: Jun Yasuhara, M.D., of Nationwide Children’s Hospital in Columbus, Ohio, and Toshiki Kuno, M.D., Ph.D., of the Albert Einstein College of Medicine in New York, are the corresponding authors.


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


This entry was posted in Uncategorized and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s